Verdence Capital Advisors’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $529K | Sell |
4,312
-985
| -19% | -$121K | 0.04% | 398 |
|
|
2025
Q1 | $536K | Buy |
5,297
+1,696
| +47% | +$172K | 0.04% | 365 |
|
|
2024
Q4 | $333K | Sell |
3,601
-69
| -2% | -$6.37K | 0.03% | 481 |
|
|
2024
Q3 | $355K | Buy |
3,670
+160
| +5% | +$15.5K | 0.03% | 470 |
|
|
2024
Q2 | $301K | Sell |
3,510
-1,977
| -36% | -$170K | 0.03% | 465 |
|
|
2024
Q1 | $453K | Sell |
5,487
-74
| -1% | -$6.11K | 0.04% | 365 |
|
|
2023
Q4 | $371K | Sell |
5,561
-19
| -0.3% | -$1.27K | 0.04% | 403 |
|
|
2023
Q3 | $375K | Buy |
5,580
+370
| +7% | +$24.9K | 0.04% | 379 |
|
|
2023
Q2 | $353K | Sell |
5,210
-488
| -9% | -$33K | 0.04% | 379 |
|
|
2023
Q1 | $308K | Buy |
5,698
+183
| +3% | +$9.9K | 0.04% | 414 |
|
|
2022
Q4 | $330K | Sell |
5,515
-160
| -3% | -$9.57K | 0.04% | 361 |
|
|
2022
Q3 | $257K | Sell |
5,675
-1,319
| -19% | -$59.7K | 0.04% | 422 |
|
|
2022
Q2 | $312K | Sell |
6,994
-270
| -4% | -$12K | 0.04% | 371 |
|
|
2022
Q1 | $411K | Buy |
7,264
+914
| +14% | +$51.7K | 0.05% | 335 |
|
|
2021
Q4 | $330K | Buy |
6,350
+2,443
| +63% | +$127K | 0.04% | 384 |
|
|
2021
Q3 | $233K | Sell |
3,907
-262
| -6% | -$15.6K | 0.03% | 440 |
|
|
2021
Q2 | $259K | Sell |
4,169
-1,330
| -24% | -$82.6K | 0.04% | 404 |
|
|
2021
Q1 | $358K | Buy |
5,499
+549
| +11% | +$35.7K | 0.06% | 304 |
|
|
2020
Q4 | $326K | Sell |
4,950
-106
| -2% | -$6.98K | 0.06% | 265 |
|
|
2020
Q3 | $261K | Sell |
5,056
-30
| -0.6% | -$1.55K | 0.06% | 279 |
|
|
2020
Q2 | $251K | Buy |
5,086
+336
| +7% | +$16.6K | 0.06% | 274 |
|
|
2020
Q1 | $242K | Buy |
4,750
+1,043
| +28% | +$53.1K | 0.07% | 242 |
|
|
2019
Q4 | $204K | Buy |
+3,707
| New | +$204K | 0.05% | 306 |
|